Product Images Duloxetine

This is a graph showing the proportion of patients with relapse over time from randomization to relapse in days for the treatment with Duloxetine and Placebo. The X-axis represents time, and the Y-axis represents the proportion of patients. The graph shows that the proportion of patients with relapse is lower for the Duloxetine treatment compared to the Placebo treatment over time.*

This is a chart that shows the percentage of patients improved in terms of pain reduction after taking different doses of Duloxetine, a medication used to treat depression and anxiety. The chart displays the percent improvement in pain from the baseline, with the highest dose of 120mg showing the most improvement (-9%), followed by 60mg (-8%), and 20mg showing no improvement (0%). The chart also includes a placebo, indicated by "XXX", which shows no improvement.*

The text represents a chart showing the percentage of patients who improved after taking Duloxetine 60/120 mg Once Daily compared to a Placebo. The percentage of improvement ranges from 0% to 100%, with the drug showing an 8% improvement above the placebo. The chart also includes a percent improvement in pain from the baseline, but specific values are not given.*

The text provides a graph showing the percentage of patients who improved when treated with Duloxetine 60 mg once daily compared to a placebo. The graph also displays the percent improvement in pain from baseline. No further information is available to provide additional context or details.*

The text provides a graph showing the percentage of patients that improved using placebo and Duloxetine 60/120 mg once daily, and the percent improvement in pain from baseline. The graph also includes numbers from 210 to 290.*

This appears to be packaging information for a medication called Cymbalta 20mg Capsule produced by Zhejiang Huahai Pharma Co., Ltd. The package was prepackaged by Bryant Ranck Prepack and comes in a pack of 30 capsules with an expiration date of MM/YY. The medication may cause drowsiness and should be stored at room temperature between 20°-25°C (68°-77°F). The last line appears to be a potentially unreliable identification number, as it contains non-English characters.*